Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
5.50
+0.06 (1.10%)
Sep 30, 2025, 4:08 PM HKT
HKG:9989 Market Cap
HKG:9989 has a market cap or net worth of 17.51 billion as of September 30, 2025. Its market cap has increased by 22.88% in one year.
Market Cap
17.51B
Enterprise Value
17.60B
Revenue
5.74B
Ranking
n/a
PE Ratio
39.47
Stock Price
5.50
Market Cap Chart
Since May 6, 2010, HKG:9989's market cap has decreased from 79.74B to 17.51B, a decrease of -78.04%. That is a compound annual growth rate of -9.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 29, 2025 | 17.49B | 16.13% |
Dec 31, 2024 | 15.06B | -10.92% |
Dec 29, 2023 | 16.91B | -12.50% |
Dec 30, 2022 | 19.32B | -30.93% |
Dec 31, 2021 | 27.97B | -0.50% |
Dec 31, 2020 | 28.11B | 3.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 279.26B |
Hansoh Pharmaceutical Group Company | 210.92B |
JD Health International | 206.50B |
Innovent Biologics | 159.71B |
WuXi Biologics | 158.73B |
Sino Biopharmaceutical | 142.12B |
Akeso | 122.24B |
Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |